Pioglitazone Tablet
Product Images NDC 57237-219

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 57237-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

The text describes the mean change in HbAlc levels in a 26-week, placebo-controlled dose-ranging study. The data is presented graphically in Figure 1, which shows the observed values for three different doses (15mg, 30mg, and 45mg) plotted over time. The x-axis represents the number of weeks in the study, while the y-axis represents the mean change in HbAlc levels from baseline.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablet Bottle))

Rising® NDC57237-220-3 is a tablet that contains Piogltazon hydrochloride, equivalent to piogitazone 30 mg. The tablet is distributed by Rising Health and manufactured in India. The recommended storage temperature is between 20°C to 25°C, and it should be protected from moisture and humidity. Pharmacists are advised to dispense the accompanying medication guide to each patient and keep it out of the reach of children. If the seal over the bottle opening is broken, do not accept the medication. No information is available on the purpose of this medication or the conditions it is used to treat.*

FDA Label Image

Package Label-principal Display Panel (45 mg (30 Tablet Bottle))

The text is a medication label for Pioglitazone tablets, USP. It provides information on the dosage, administration, storage, and distribution of the medication. The pharmacist is advised to dispense the accompanying medication guide to each patient. The medication is distributed by Rising Health, LLC, Saddle Brook, NJ. It also includes a code and a revision date.*

FDA Label Image

Chemical Structure (Pioglitazone Str)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.